Merit Medical SystemsFRA:MM3 +1.74%86 OCF Margin % is 10.65% as of Mar. 2026, which is 1% below its 10-year median of 10.74. GuruFocus rates FRA:MM3 with a GF Score™ of 86/100 and a GF Value™ of €81.73 (Modestly Undervalued). Among 815 Medical Devices & Instruments companies, Merit Medical Systems ranks better than 77.3% on this metric.
The historical rank and industry rank for Merit Medical Systems's OCF Margin % or its related term are showing as below:
FRA:MM3'
s OCF Margin % Range Over the Past 10 Years
Min: 7.82 Med: 10.74 Max: 19.62
Current: 19.27
During the past 13 years, the highest OCF Margin % of Merit Medical Systems was 19.62%. The lowest was 7.82%. And the median was 10.74%.
FRA:MM3's OCF Margin % is ranked better than 77.3% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs FRA:MM3: 19.27
Merit Medical Systems OCF Margin % Related Terms
Merit Medical Systems OCF Margin % Historical Data
* Premium members only.
The historical data trend for Merit Medical Systems's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MM3 vs NVST, MMED, ICUI: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Merit Medical Systems's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merit Medical Systems OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Merit Medical Systems's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merit Medical Systems (FRA:MM3) has a OCF Margin % of 10.65% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Merit Medical Systems and its competitors. This is near median its historical median of 10.74. Over the past decade, Merit Medical Systems' OCF Margin % has ranged from 7.82 to 19.62. According to the industry distribution chart, Merit Medical Systems ranks #185 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 22.7%.
Is Merit Medical Systems' OCF Margin % too high?
Merit Medical Systems' current OCF Margin % of 10.65% is near median its 10-year median of 10.74. Over the past 10 years, this metric has ranged from a low of 7.82 to a high of 19.62. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Merit Medical Systems' value of 10.65% is 81.7% above this industry median. Based on the distribution chart, Merit Medical Systems ranks #185 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Merit Medical Systems has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' OCF Margin % compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #185 out of 815 companies for OCF Margin %. This places Merit Medical Systems in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Merit Medical Systems' value of 10.65% is 81.7% above this benchmark. Historically, Merit Medical Systems' own OCF Margin % has ranged from 7.82 to 19.62 over the past decade. While the company's 10-year median is 10.74 vs. the industry median of 5.86, Merit Medical Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merit Medical Systems's current OCF Margin % of 10.65% is 81.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Merit Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merit Medical Systems's current OCF Margin % is 10.65%, which is near median its own 10-year median of 10.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (FRA:MM3) is currently considered Modestly Undervalued. The stock's GF Value™ is €81.73, compared to a current price of €58.50 — trading 28.4% below its estimated fair value. The current OCF Margin % is 10.65%, which is near median its 10-year median of 10.74 and 81.7% above the Medical Devices & Instruments industry median of 5.86. Merit Medical Systems' overall GF Score™ is 86/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current OCF Margin % is 10.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?
Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued.
The current stock price of €58.50 is trading 28.4% below its estimated GF Value™ of €81.73.
GuruFocus considers Merit Medical Systems to be Modestly Undervalued.
Key valuation signals for FRA:MM3:
OCF Margin %: 10.65% (near median its 10-year median of 10.74)
GF Value™: €81.73 vs. price of €58.50 (28.4% below fair value)
Industry Position: 81.7% above the Medical Devices & Instruments median (#185 of 815)
No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
86GF Score
Get the complete analysis for FRA:MM3
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM3 has been successfully added to your 
